Mina Matsuda-Abedini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mina Matsuda-Abedini has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Adam Rapoport
Paediatric Advanced Care Team Hospital for Sick Children Toronto Ontario Canada
1 shared publication Alexandra Romann
Provincial Health Services Authority
1 shared publication- Allison B. Dart
University of Manitoba, Winnipeg, Manitoba, Canada
1 shared publication - Banke Oketola
University of Manitoba, Children’s Hospital Research Institute of Manitoba, Winnipeg, Canada
1 shared publication Chanel Prestidge
Division of Nephrology, British Columbia Children's Hospital, 4480 Oak Street, Vancouver, BC, V6H 3V4, Canada
1 shared publicationClaire Adams
Division of Pediatric Nephrology, Department of Pediatrics, McMaster University, Hamilton, ON, Canada
1 shared publication
Latest Publications
- Open Access
- 28 February 2026
- Published by SAGE Publications in Canadian Journal of Kidney Health and Disease
- Vol. 13
Implementation of a Novel Patient-Reported Outcome Measure for the Assessment of Symptoms in Children Living With Chronic Kidney Disease (PRO-Kid)—Program Report
Purpose of the Program: Children with chronic kidney disease (CKD) experience significant physical and psychological symptoms, necessitating patient-reported outcome (PRO) measurement tools to quantify symptoms, and to improve communication between children with CKD and their health care providers. This study aimed to implement the novel PRO-Kid tool into pediatric CKD and dialysis programs in Canada. Sources of Information: The PRO-Kid tool is a novel 14-item questionnaire that was developed and validated by our research team, in partnership with patients living with childhood-onset CKD and caregivers for children with G3-G5 CKD, including dialysis. PRO-Kid measures both the frequency and impact of CKD symptoms in children ages eight to 18 years. It showed strong internal consistency and validity, as demonstrated by a Cronbach alpha of .83 (95% confidence interval [CI], 0.78-0.88) for the frequency scale, and .84 (95% CI, 0.80-0.89) on the impact scale. Methods: The PRO-Kid tool is being implemented in seven Pediatric Nephrology Programs across Canada. Guided by the Consolidated Framework for Implementation Research (CFIR), organizational readiness at each of the sites was assessed via surveys and focus groups. To date, the PRO-Kid tool (eight- to 18-year-old version) and site-specific toolkits have been implemented at three sites that were ready to launch (HSC, Winnipeg; BC Children’s Hospital, Vancouver; and McMaster Children’s Hospital, Hamilton). Implementation outcomes, such as the number of patients reached and patient and provider satisfaction, were evaluated using audits, surveys, and focus groups guided by the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework. Key Findings: The organizational readiness assessment identified different electronic medical records and preferences for paper-based data collection methods across sites as well as the need to translate the PRO-Kid tool into other languages. Preliminary evaluation revealed that PRO-Kid is easy to use and is satisfactory to both patients and health care providers. Local champions were identified as key facilitators of implementation efforts. PRO-Kid can help improve communication between children with CKD and their health care providers in identifying symptoms that may not otherwise come up (be disclosed) during clinical encounters. However, language and low reading levels are barriers for some children, and unavailability of clinical staff can limit the use of the tool at some sites. Implications: Local teams will be required to play crucial roles in integrating the use of the tool in clinical settings. To ensure the tool can be applied across diverse populations, the validation of PRO-Kid tool two to four years old, five to seven years old, and French versions are ongoing. The availability of different versions of the tool will ensure equitable access and promote sustainability of the tool.
- 28 February 2026
- Published by SAGE Publications in Canadian Journal of Kidney Health and Disease
- Vol. 13
Open AccessImplementation of a Novel Patient-Reported Outcome Measure for the Assessment of Symptoms in Children Living With Chronic Kidney Disease (PRO-Kid)—Program Report
Purpose of the Program: Children with chronic kidney disease (CKD) experience significant physical and psychological symptoms, necessitating patient-reported outcome (PRO) measurement tools to quantify symptoms, and to improve communication between children with CKD and their health care providers. This study aimed to implement the novel PRO-Kid tool into pediatric CKD and dialysis programs in Canada. Sources of Information: The PRO-Kid tool is a novel 14-item questionnaire that was developed and validated by our research team, in partnership with patients living with childhood-onset CKD and caregivers for children with G3-G5 CKD, including dialysis. PRO-Kid measures both the frequency and impact of CKD symptoms in children ages eight to 18 years. It showed strong internal consistency and validity, as demonstrated by a Cronbach alpha of .83 (95% confidence interval [CI], 0.78-0.88) for the frequency scale, and .84 (95% CI, 0.80-0.89) on the impact scale. Methods: The PRO-Kid tool is being implemented in seven Pediatric Nephrology Programs across Canada. Guided by the Consolidated Framework for Implementation Research (CFIR), organizational readiness at each of the sites was assessed via surveys and focus groups. To date, the PRO-Kid tool (eight- to 18-year-old version) and site-specific toolkits have been implemented at three sites that were ready to launch (HSC, Winnipeg; BC Children’s Hospital, Vancouver; and McMaster Children’s Hospital, Hamilton). Implementation outcomes, such as the number of patients reached and patient and provider satisfaction, were evaluated using audits, surveys, and focus groups guided by the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework. Key Findings: The organizational readiness assessment identified different electronic medical records and preferences for paper-based data collection methods across sites as well as the need to translate the PRO-Kid tool into other languages. Preliminary evaluation revealed that PRO-Kid is easy to use and is satisfactory to both patients and health care providers. Local champions were identified as key facilitators of implementation efforts. PRO-Kid can help improve communication between children with CKD and their health care providers in identifying symptoms that may not otherwise come up (be disclosed) during clinical encounters. However, language and low reading levels are barriers for some children, and unavailability of clinical staff can limit the use of the tool at some sites. Implications: Local teams will be required to play crucial roles in integrating the use of the tool in clinical settings. To ensure the tool can be applied across diverse populations, the validation of PRO-Kid tool two to four years old, five to seven years old, and French versions are ongoing. The availability of different versions of the tool will ensure equitable access and promote sustainability of the tool.
- 9 August 2011
- Published by Springer Nature in Pediatric Nephrology
- Vol. 27 (2) , 295-302
Utility and cost of a renal transplant transition clinic
Successful transition from paediatric-centred to adult-oriented healthcare positively influences health outcomes for youth with chronic illness. The primary objective is to evaluate outcomes pre- and post provision of multidisciplinary transition clinic (TC) care to renal transplant recipients. We compared patient and allograft survival in renal transplant recipients at British Columbia Children’s Hospital who received care within a transition clinic (TC) to a cohort of patients transferred prior to establishment of the TC, pre-TC (PTC) in 2007. Baseline characteristics, allograft function, and survival data were collected prospectively via a validated provincial database for 2 years posttransfer. We also estimated and compared the average yearly per-patient cost during the 2-year follow-up period. Thirty-three patients were transferred (PTC) and 12 transitioned (TC). In the PTC cohort, there was a combined poor outcome (death or allograft loss) incidence of 24% within 2 years posttransfer compared with no death or allograft loss in the TC cohort. Cost estimates indicate the average yearly per-patient cost was Canadian dollars (CAD) $17,127–$38,909 for the PTC and CAD $11,380–$34,312 for the TC cohort. For PTC patients who lost their allograft and returned to dialysis, the per-patient cost was CAD $40,956–$61,470. Our results indicate improved allograft and patient survival posttransfer of care in renal transplant recipients who attended TCs, and we found that providing TCs is economically feasible.
- 9 August 2011
- Published by Springer Nature in Pediatric Nephrology
- Vol. 27 (2) , 295-302
Utility and cost of a renal transplant transition clinic
Successful transition from paediatric-centred to adult-oriented healthcare positively influences health outcomes for youth with chronic illness. The primary objective is to evaluate outcomes pre- and post provision of multidisciplinary transition clinic (TC) care to renal transplant recipients. We compared patient and allograft survival in renal transplant recipients at British Columbia Children’s Hospital who received care within a transition clinic (TC) to a cohort of patients transferred prior to establishment of the TC, pre-TC (PTC) in 2007. Baseline characteristics, allograft function, and survival data were collected prospectively via a validated provincial database for 2 years posttransfer. We also estimated and compared the average yearly per-patient cost during the 2-year follow-up period. Thirty-three patients were transferred (PTC) and 12 transitioned (TC). In the PTC cohort, there was a combined poor outcome (death or allograft loss) incidence of 24% within 2 years posttransfer compared with no death or allograft loss in the TC cohort. Cost estimates indicate the average yearly per-patient cost was Canadian dollars (CAD) $17,127–$38,909 for the PTC and CAD $11,380–$34,312 for the TC cohort. For PTC patients who lost their allograft and returned to dialysis, the per-patient cost was CAD $40,956–$61,470. Our results indicate improved allograft and patient survival posttransfer of care in renal transplant recipients who attended TCs, and we found that providing TCs is economically feasible.
- 7 October 2009
- Published by Wiley in Pediatric Transplantation
- Vol. 13 (7) , 856-860
Outcome of kidney transplantation in Canadian Aboriginal children in the province of British Columbia
Abstract: Renal transplantation remains the therapy of choice for children and adolescents with ESRD. Differences in graft survival are observed in kidney transplant recipients of different race and ethnicities. Data in pediatric populations are limited and confounded by disparities in access to health care. We performed a retrospective single Canadian centre database review to determine the short‐ and long‐term outcomes of kidney transplantation in Aboriginal children compared to non‐Aboriginals. A total of 159 primary renal transplant recipients at BCCH between 1985 and 2005 were examined (15% Aboriginal). Aboriginal children had different etiologies of ESRD, and a higher percentage of females, but were similar in age at transplantation, cold ischemia time and living donation rate. Early graft outcomes such as delayed graft function, episodes of acute rejection in the first year post‐transplant and estimated glomerular function rate at one yr were similar in both groups. Long‐term graft survival, however, was significantly worse in the Aboriginal group, with a significantly increased rate of late rejections: 50% compared with 26.7% among non‐Aboriginals (p = 0.03). In a province with uniform access to health care, significant differences in long‐term graft outcome exist among Aboriginal children compared with non‐Aboriginals.
- 7 October 2009
- Published by Wiley in Pediatric Transplantation
- Vol. 13 (7) , 856-860
Outcome of kidney transplantation in Canadian Aboriginal children in the province of British Columbia
Abstract: Renal transplantation remains the therapy of choice for children and adolescents with ESRD. Differences in graft survival are observed in kidney transplant recipients of different race and ethnicities. Data in pediatric populations are limited and confounded by disparities in access to health care. We performed a retrospective single Canadian centre database review to determine the short‐ and long‐term outcomes of kidney transplantation in Aboriginal children compared to non‐Aboriginals. A total of 159 primary renal transplant recipients at BCCH between 1985 and 2005 were examined (15% Aboriginal). Aboriginal children had different etiologies of ESRD, and a higher percentage of females, but were similar in age at transplantation, cold ischemia time and living donation rate. Early graft outcomes such as delayed graft function, episodes of acute rejection in the first year post‐transplant and estimated glomerular function rate at one yr were similar in both groups. Long‐term graft survival, however, was significantly worse in the Aboriginal group, with a significantly increased rate of late rejections: 50% compared with 26.7% among non‐Aboriginals (p = 0.03). In a province with uniform access to health care, significant differences in long‐term graft outcome exist among Aboriginal children compared with non‐Aboriginals.